Global Contraceptive Drug Eluting Devices Market Growth 2026-2032
Description
The global Contraceptive Drug Eluting Devices market size is predicted to grow from US$ 4373 million in 2025 to US$ 5743 million in 2032; it is expected to grow at a CAGR of 4.0% from 2026 to 2032.
Contraceptive Drug-Eluting Devices are medical devices designed to release contraceptive drugs over a prolonged period to prevent pregnancy. These devices are implanted in the body or placed in specific areas, gradually releasing hormones that inhibit ovulation or prevent sperm from fertilizing an egg. Common examples include intrauterine devices (IUDs) and subdermal implants, which are effective, reversible, and provide long-term contraception without requiring daily action.
United States market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contraceptive Drug Eluting Devices players cover Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Contraceptive Drug Eluting Devices Industry Forecast” looks at past sales and reviews total world Contraceptive Drug Eluting Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptive Drug Eluting Devices sales for 2026 through 2032. With Contraceptive Drug Eluting Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Drug Eluting Devices industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Drug Eluting Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Drug Eluting Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contraceptive Drug Eluting Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Drug Eluting Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Drug Eluting Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Drug Eluting Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-biodegradable
Biodegradable
Segmentation by Application:
Subcutaneously
Uterus
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
AbbVie
CooperSurgical
Egemen International
ERENLER MEDIKAL
Gyneas
Laboratoire CCD
Medical Engineering Corporation
Melbea
Meril Life Sciences
Mona Lisa
Pregna International
Prosan International
Rongbo Medical
SMB Corporation of India
Pregna
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptive Drug Eluting Devices market?
What factors are driving Contraceptive Drug Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Drug Eluting Devices market opportunities vary by end market size?
How does Contraceptive Drug Eluting Devices break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Contraceptive Drug-Eluting Devices are medical devices designed to release contraceptive drugs over a prolonged period to prevent pregnancy. These devices are implanted in the body or placed in specific areas, gradually releasing hormones that inhibit ovulation or prevent sperm from fertilizing an egg. Common examples include intrauterine devices (IUDs) and subdermal implants, which are effective, reversible, and provide long-term contraception without requiring daily action.
United States market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contraceptive Drug Eluting Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contraceptive Drug Eluting Devices players cover Bayer, AbbVie, CooperSurgical, Egemen International, ERENLER MEDIKAL, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Contraceptive Drug Eluting Devices Industry Forecast” looks at past sales and reviews total world Contraceptive Drug Eluting Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Contraceptive Drug Eluting Devices sales for 2026 through 2032. With Contraceptive Drug Eluting Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contraceptive Drug Eluting Devices industry.
This Insight Report provides a comprehensive analysis of the global Contraceptive Drug Eluting Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contraceptive Drug Eluting Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contraceptive Drug Eluting Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contraceptive Drug Eluting Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contraceptive Drug Eluting Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Contraceptive Drug Eluting Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-biodegradable
Biodegradable
Segmentation by Application:
Subcutaneously
Uterus
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
AbbVie
CooperSurgical
Egemen International
ERENLER MEDIKAL
Gyneas
Laboratoire CCD
Medical Engineering Corporation
Melbea
Meril Life Sciences
Mona Lisa
Pregna International
Prosan International
Rongbo Medical
SMB Corporation of India
Pregna
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptive Drug Eluting Devices market?
What factors are driving Contraceptive Drug Eluting Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptive Drug Eluting Devices market opportunities vary by end market size?
How does Contraceptive Drug Eluting Devices break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
134 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Contraceptive Drug Eluting Devices by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Contraceptive Drug Eluting Devices by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
